Peptidylprolyl Isomerase A (Cyclophilin A)
PPIAproteinPPIA downregulation in acute MI reflects disruption of intracellular protein folding and cellular stress in ischemic myocardium.
Pathway placement
Cascade stepMyocardial injury (shared endpoint)
Confidencemedium
RationaleMI biomarker downregulated in acute MI; intracellular chaperone altered during cardiomyocyte damage.
Druggability
DruggableYes
Known drugs / candidates3
Small-molecule tractableYes
Antibody tractableYes
EnsemblENSG00000196262
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum or plasma
Collection tube
Serum separator (gold/red-top, SST) · K2/K3-EDTA (lavender-top)
Method / principle
Sandwich immunoassay (ELISA) — research-grade unless a cleared assay exists
Reagent / substrate
Matched anti-target antibody pair (capture + labeled detection)
Platform
ELISA microplate or multiplex (Luminex/MSD)
Turnaround · availability
Send-out / research · Research-grade (no universal clinical assay)
Human genetic evidence
0.326
Open Targets association (STEMI)
Literature evidence(2)
- Plasma Exosomal Proteomics Identifies Differentially Expressed Proteins as Biomarkers for Acute Myocardial Infarction.Biomolecules · 2025 · PMID 40305362 · doi
- Discovery of potential plasma protein biomarkers for acute myocardial infarction via proteomics.Journal of thoracic disease · 2019 · PMID 31656670 · doi